Patients with alopecia areata who did not respond to initial treatment with a JAKi or who did not maintain response may ...

While medical treatments are usually the first port of call, a lot of people find a sense of peace (and some pretty great ...

Topical immunotherapy remains an effective, affordable option for alopecia areata, with long-term control seen in multimodal treatment approaches. Topical immunotherapy continues to have a significant ...

PATIENTS with severe alopecia areata treated with upadacitinib achieved greater hair regrowth at Week 24 versus placebo. Upadacitinib in Severe Alopecia Areata. New subgroup data ...

Treatment speed and patient perception are emerging as key factors in managing pattern hair loss, especially as many patients ...

Louis Theroux has revealed that his alopecia worsened while filming his Netflix documentary Inside the Manosphere, saying his ...

HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases ...

Maria Hordinsky, MD, discusses the promise of Janus kinase (JAK) inhibitors in treating alopecia areata in the long term.

The breadth of data reinforces the company's expertise across dermatology and immunology, and reflects the ongoing commitment to safe, effective medications ...

Doctors break it down.

Researchers have found in a multicentre real-world study that ritlecitinib 50 mg/day was found to be an effective and ...